To test the effects of XPro1595 on the cellular immune profile in a phase I study for InmuneBio

Project: Research

Project Description

To test blood cells from a small cohort of cancer patients treated with Xpo1595 (INB03 ), a dominant negative TNF blocking drug. This is being performed for a firm in the USA called INmuneBIO
Short titleINmuneBio project
StatusFinished
Effective start/end date1/05/1830/04/19